Insilico Medicine, Asia Genomics Partner on Longevity Research | GenomeWeb

NEW YORK (GenomeWeb) – Insilico Medicine announced today that it has partnered with Singapore-based molecular diagnostics firm Asia Genomics to develop biomarkers of aging and longevity for Asian populations.

Under the terms of the deal, the companies will identify personalized aging-related biomarkers based on individuals' age-annotated genomic and transcriptomic data. They also aim to develop an age-predicting algorithm that will be incorporated into multiple deep neural networks trained and tested on Asian blood chemistry samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.